Advertisement

Pharmaceutisch weekblad

, Volume 3, Issue 1, pp 737–744 | Cite as

Immunoglobulinen en virusinfecties

  • H. G. J. Brummelhuis
  • P. Th. A. Schellekens
Overzichtsartikelen
  • 22 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Geraadpleegde literatuur

Inleiding

  1. Notkins, A.L. (1974)Hosp. Pract. 9, 65.CrossRefGoogle Scholar
  2. Schellekens, H. (1981)Pharm. Weekblad 116, 469–477.CrossRefGoogle Scholar

Metabolisme van het inmumoglobuline

  1. Out, T.A. (1981)Pharm. Weekblad 116, 68–77.CrossRefGoogle Scholar
  2. Rout, J. (1974)Essential Immunology, 2nd ed. Blackwell Scientific Publications, Oxford.Google Scholar
  3. Waldman, Th.A., enW. Strober (1976)Clinical Immunobiology, Vol. 3, 1st ed. Academic Press Inc., Londen, 71–95.Google Scholar

Bereiding van normaal en specifiek immunoglobulineconcentraat

  1. Cohn, E.J., L.E. Strong, W.L. JR.Hughes, D.J. Mulford, J.N. Ashworth, M. Melin enH.L. Taylor (1946)J. Am. Chem. Soc. 68, 459–475.CrossRefPubMedGoogle Scholar
  2. Vogelaar, E.F., M.A.G. De Boer-Van Den Berg, H.G.J. Brummelhuis, S.P. Beentjes enH.W. Krijnen (1974)Vox Sanguinis 27, 193–206.CrossRefPubMedGoogle Scholar
  3. Kistler, P., enH. Friedli (1980)Methods of Plasma Protein Fractionation, 1st ed. Academic Press Inc., Londen, 3–15.Google Scholar

Controle van gehalte en zuiverheid

  1. Nederlandse Farmacopee (1978) Deel 11 8e ed., 645; 647; 648–650.Google Scholar
  2. WHO (1975)Technical Report Series 567, 16–28;Ibidem (1978)626, 62–86.Google Scholar

Toepassingen

  1. Centre for disease control (1977)Morbid. Mortal. Weekly Rep. 25, 425.Google Scholar
  2. Immunoglobulinen (1975)Geneesmiddelenbulletin 9, 25.Google Scholar
  3. Krugman, S. (1979)Gastroenterology 77, 187.Google Scholar
  4. Krugman, S., R. Ward enJ. P. Giles (1976)Am. J. Med. 32, 717.CrossRefGoogle Scholar
  5. Mosely, L. (1979)Gastroenterology 77, 187.Google Scholar
  6. Tol, F.H., enP.F. Wehrle (Eds.) (1976)Communicable and infectious diseases. The C.V. Mosby Company, St. Louis.Google Scholar
  7. Seeff, L.B., enJ.H. Hoofnagle (1979)Gastroenterology 77, 161.PubMedGoogle Scholar
  8. Stiehm, E.R., enV.A. Fulginiti (1980)Immunologic disorders in infants and children. W.B. Saunders Company, Philadelphia - Londen - Toronto, 660–687.Google Scholar
  9. Urguhart, G.E.D., R.J. Crawford enJ. Wallace (1978)Brit. Med. J. 2, 1331.CrossRefGoogle Scholar
  10. Vermey-Keers, Chr., J. Versteeg enJ. Gravenhorst-Bennebroek (1977)Ned. Tijdschr. Geneesk. 31, 1224.Google Scholar
  11. Zaia, J.A., J.L. Myrow enS.R. Preblud (1980) In:Immunoglobulins: Characteristics and uses of intravenous preparations (Alving, B.M., enJ.S. Finlayson, Eds.). US Department of Health and Human Services Washington DC, 111–123.Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1981

Authors and Affiliations

  • H. G. J. Brummelhuis
    • 1
  • P. Th. A. Schellekens
    • 1
  1. 1.Centraal Laboratorium van de BloedtransfusiedienstAD Amsterdam

Personalised recommendations